Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)

Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

NCT00460811 ·Status: COMPLETED ·Phase: PHASE2

Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome

NCT02316899 ·Status: COMPLETED ·Phase: PHASE3

A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

NCT03573908 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

NCT01880424 ·Status: COMPLETED ·Phase: PHASE3

Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation

NCT00948818 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome

NCT01714843 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Safety of Linaclotide in IBS-C Patients in China

NCT04462900 ·Status: COMPLETED

Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients

NCT02078323 ·Status: COMPLETED ·Phase: NA

Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C

NCT04166058 ·Status: COMPLETED ·Phase: PHASE3

Assessment of Responsiveness to Treatment by Experience Sampling Method

NCT03336034 ·Status: TERMINATED

Cognitive and Psychiatric Effects of Linaclotide on Patients With Constipation

NCT03342287 ·Status: WITHDRAWN

Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)

NCT00607971 ·Status: TERMINATED ·Phase: PHASE3

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

NCT01722318 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C)

NCT02837783 ·Status: TERMINATED ·Phase: PHASE4

Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)

NCT02493452 ·Status: COMPLETED ·Phase: PHASE3

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

NCT02387359 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C)

NCT03596905 ·Status: COMPLETED ·Phase: PHASE2

Long Term Safety Study of Plecanatide

NCT02706483 ·Status: COMPLETED ·Phase: PHASE3

Study of LX1031 in Subjects With Non-Constipating Irritable Bowel Syndrome

NCT00813098 ·Status: COMPLETED ·Phase: PHASE2

Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide

NCT00584298 ·Status: COMPLETED ·Phase: PHASE1

Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)

NCT04043455 ·Status: TERMINATED ·Phase: PHASE2

The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients

NCT02254629 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syndrome With Predominant Constipation

NCT01027260 ·Status: COMPLETED ·Phase: PHASE2

Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in China

NCT02955316 ·Status: COMPLETED

The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)

NCT01923428 ·Status: COMPLETED ·Phase: PHASE2/PHASE3